5.0
Walgreens Boots Alliance, Inc. is a U.S.-based company operating in the retail-pharmacy sector, formed from the merger of Walgreens Co. and Alliance Boots. The merger positioned the company among the world’s leading global players in health, wellness, and pharmaceutical retail.
Through its brands—Walgreens, Boots, and Duane Reade—the company offers a broad range of products and services, including prescription and over-the-counter medications, health and wellness items, beauty and hygiene products, and integrated healthcare services such as pharmacy care, vaccination, and primary care.
Its portfolio encompasses retail pharmacies, drug distribution, e-commerce operations, and digital healthcare services, supported by a robust international infrastructure spanning multiple countries. This diversified global presence enables resilience and market adaptability across different regions.
The company operates a large workforce and maintains a global footprint via hundreds of stores, distribution centers, and healthcare service points. Its business model combines physical retail, supply-chain logistics, online channels, and integrated health services.
Walgreens Boots Alliance, Inc. shares are traded on the Nasdaq Stock Market under the ticker WBA.
History and when Walgreens Boots Alliance, Inc. was created
Walgreens Boots Alliance, Inc. was founded in 2014 in the United States, as a result of the merger between Walgreens Co. and Alliance Boots. The union created the first globally integrated company in the pharmacy and healthcare retail sector.
In the initial years following the merger, the company focused on integrating operations and expanding internationally. With an established presence in the United States and Europe, it strengthened its e-commerce presence and expanded its in-store clinical services, including pharmacy care and vaccination services.
Beginning around 2018, the company intensified investments in technology, service digitization, and strategic partnerships with healthcare and tech networks to broaden its medical-service offerings.
In 2020, during the COVID-19 pandemic, Walgreens Boots Alliance played a critical role in vaccine distribution and medication supply, which accelerated the digitalization of its services and boosted the healthcare segment within its retail network.
Between 2021 and 2024, the company reportedly undertook significant restructuring by divesting non-core assets and refocusing its business on integrated health services and personalized patient care, aiming to reinforce competitiveness in the global market.
Additional Information
The Company Walgreens Boots Alliance Inc. (United States), is listed on Nasdaq with a market value of $ 10.36 Billions, having an equity of $ 7.32 Billions.
With a total of 331.000 employees, the company is listed in the sector of Services and categorized in industry of Retail Trade of Medicines.
In the last 12 months the Company had a revenue of $ 155.62 Billions, which generated a loss in the amount of $ -6.15 Billions.
As for its main indicators, the Company has a P/E ratio of -1.76, a P/BV ratio of 1.42 and in the last 12 months the dividend yield of WBA was at 4.17%.
The Company is traded internationally through the ticker WBA.
